tirzepatide (Mounjaro, Zepbound) Same rationale no documented interaction
The post says they typically emerge in the first one to two weeks of therapy or after a dose escalation, and puts the frequency at roughly five to ten percent of patients
Furthermore, as mentioned before (see Section 2.1, Isoprenaline-myocardial infarction [38]), we demonstrated that, in addition to the isoprenaline-myocardial infarction [38], the other major noxious events [31,37,38,39,40] also acutely caused the prominent heart failure and widespread dysfunction similar to that observed in rats after the occlusion of the peripheral [19,24,29] and central [27] vessels
And, and that's just safe skincare is, you know, the baseline